Investment opportunities

A disruptive solution to support life for the most premature babies

We instantly transform complex medical images into Digital Immersive Twins (DITs) that specialists and patients can understand.

Developing the world's smallest brush for the early diagnosis of pancreatic cancer

Cambridge-based biotech developing innovative cell, protein and extracellular vesicle delivery technologies, with €1.3M+ in annual revenue.

BraiN20®, The First and Only Real-time, Portable, AI-powered Stroke Monitoring Medical Device.

Next-generation oral cancer treatment, with pharmaceutical interest for potential partnerships as early as 2027

Aspivix introduces a non-invasive alternative to the cervical tenaculum, improving accessibility to effective contraception.

TheraSonic develops a robot-guided ultrasound system to temporarily open the blood–brain barrier and boost drug delivery to the brain.

Stereodive automates neurological planning to improve surgical safety for epilepsy, brain tumors, Parkinson’s and other movement disorders

Cardiawave transforms Aortic Stenosis care with a Non-Invasive Ultrasound Therapy for patients ineligible for immediate valve replacement

Womed is pioneering innovative, safe and effective intrauterine therapies to relieve women from challenging uterine diseases and conditions

V4Cure develops disruptive medicine form a drug discovery platform with animal venoms.